Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
- 8 February 2014
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 232 (4) , 473-481
Abstract
Up‐regulated expression of telomerase reverse transcriptase (TERT) and subsequent maintenance of telomere length are essential in tumour development. Recent studies have implicated somatic gain‐of‐function mutations at the TERT promoter as one of the mechanisms that promote transcriptional activation of TERT; however, it remains unclear whether this genetic abnormality is prevalent in gynaecological neoplasms. We performed mutational analysis in a total of 525 gynaecological cancers, and correlated TERT promoter mutations with clinicopathological features. With the exception of ovarian clear cell carcinomas, in which mutations were found in 37 (15.9%) of 233 cases, the majority of gynaecological malignancies were wild‐type. TERT promoter mutation does not appear to be an early event during oncogenesis, as it was not detected in the contiguous endometriosis associated with ovarian clear cell carcinoma. Ovarian clear cell carcinoma cell lines with TERT promoter mutations exhibited higher TERT mRNA expression than those with wild‐type sequences (p = 0.0238). TERT promoter mutation tended to be mutually exclusive with loss of ARID1A protein expression (p = 4.4 × 10–9) and PIK3CA mutation (p = 0.0019) in ovarian clear cell carcinomas. No associations with disease‐specific survival were observed for ovarian clear cell carcinoma. The above results, in conjunction with our previous report showing longer telomeres in ovarian clear cell carcinomas relative to other types of ovarian cancer, suggests that aberrations in telomere biology may play an important role in the pathogenesis of ovarian clear cell carcinoma. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 44 references indexed in Scilit:
- Highly prevalentTERTpromoter mutations in bladder cancer and glioblastomaCell Cycle, 2013
- Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular studyThe Lancet Oncology, 2013
- Reciprocal Regulation of Akt and Oct4 Promotes the Self-Renewal and Survival of Embryonal Carcinoma CellsMolecular Cell, 2012
- Signaling Network Crosstalk in Human Pluripotent Cells: A Smad2/3-Regulated Switch that Controls the Balance between Self-Renewal and DifferentiationCell Stem Cell, 2012
- Telomeres and Cancer: From Crisis to Stability to Crisis to StabilityCell, 2012
- EGFR overexpression induces activation of telomerase via PI3K/AKT‐mediated phosphorylation and transcriptional regulation through Hif1‐alpha in a cellular model of oral–esophageal carcinogenesisCancer Science, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- Telomerase and cancer therapeuticsNature Reviews Cancer, 2008
- Expression Profiling in Ovarian Clear Cell CarcinomaThe American Journal of Pathology, 2003
- Alternative lengthening of telomeres in mammalian cellsOncogene, 2002